Purchase Order SPE2DS20P2292
- Not listed
- This federal contract award, valued at $7,840.38, was made by the Defense Health Agency (DHA) to Nxstage Medical, Inc., a foreign-owned, for-profit medical device and supply manufacturer. The contract is a firm fixed-price purchase order for the delivery of medical equipment and supplies, including dialysis-related products such as hemodialysis machines, continuous renal replacement therapy (CRRT) systems, and dialysis cartridges. Nxstage Medical holds two significant federal contract indefinite...
- This federal contract award, valued at $4,616.40, was issued by the Defense Health Agency (DHA) to Nxstage Medical, Inc., a foreign-owned, for-profit medical device and supply manufacturer. The award is for the provision of hemodialysis solutions, which are critical medical supplies needed to support healthcare for military personnel and veterans during the Coronavirus COVID-19 pandemic. Nxstage Medical, Inc. is an experienced federal contractor, holding two significant indefinite delivery...
- This contract award, valued at $32,000.00, was made by the Defense Health Agency (DHA) to Nxstage Medical, Inc. (Nxstage) to provide the NXSTAGE SYSTEM ONE S, a medical device for the treatment of chronic or acute kidney failure. Nxstage is a foreign-owned, for-profit manufacturer of dialysis systems and supplies. This award is part of a larger $50 million indefinite delivery, indefinite quantity (IDIQ) contract under the Department of Veterans Affairs' (VA) Health Administration Equipment...
- This federal contract award, with the ID SPE2DS20P2219, was issued by the Medical Supply Chain division of the Defense agency to Nxstage Medical, Inc., a foreign-owned, for-profit medical device and supply manufacturer. The $2,613.46 firm fixed-price purchase order is for the delivery of medical equipment and supplies, including cartridge purification systems, to support federal healthcare providers. Nxstage Medical holds two significant federal contract vehicles with the Department of...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Nxstage Medical, Inc., a foreign-owned, for-profit medical device manufacturer. The contract, valued at $32,000.00, is for the provision of NxStage disposables, with an ultimate completion date of October 19, 2016. The contract is part of an Indefinite Delivery, Indefinite Quantity (IDIQ) vehicle, which suggests it may be one of multiple task orders or delivery orders under a larger contract. Nxstage is a key...
- This is a federal purchase order contract awarded by the Defense Health Agency, a component of the Department of Defense, to Nxstage Medical, Inc., a medical device and supply manufacturer. The $14,865 firm fixed-price contract is for the delivery of hemodialysis solutions, a critical medical product used in the treatment of kidney failure. The contract was awarded on April 5, 2020 in response to a competitive solicitation issued to address COVID-19 medical requirements, with a delivery deadline...
- This is a federal contract award to Nxstage Medical, Inc., a foreign-owned for-profit manufacturer of medical devices and supplies for the treatment of chronic or acute kidney failure. The contract, awarded by the Department of the Army Medical Command, is for the delivery of nephrology and dialysis supplies. The contract is a firm fixed-price delivery order with a potential value of $50,000.00. The contract does not have a set-aside designation. Through this award and other major federal...
- The U.S. Defense Health Agency awarded a $162,000.00 firm fixed-price purchase order to Nxstage Medical, Inc., a foreign-owned, for-profit medical device manufacturer, for the annual preventive maintenance of hemodialysis units and Nxstage maintenance. The contract has an ultimate completion date of November 30, 2027. Nxstage has received multiple federal contract awards, including a $3.125 million Federal Supply Schedule contract with the Department of Veterans Affairs and a $50 million...
- This firm fixed-price federal contract award, valued at $90,225.00, was issued by the Defense Health Agency (DHA) to Nxstage Medical, Inc. for the delivery of a portable hemodialysis system. The contract does not have a set-aside designation. Nxstage Medical, Inc. is a foreign-owned, for-profit manufacturer of medical devices and supplies for the treatment of chronic or acute kidney failure. The company has received numerous prime contract awards from federal agencies like the Department of...
- This is a $102,745.01 firm fixed-price purchase order awarded by the Defense Health Agency to Nxstage Medical, Inc., a foreign-owned for-profit manufacturer of medical devices and supplies. The contract is for the delivery of new cartridges and solutions for renal (kidney) applications and is not set aside for any particular business type. The award is associated with the H-1 Upgrades (4BW/4BN) major defense program, which is likely related to the procurement of hemodialysis and other renal care...
This federal contract award, valued at $10,584.40, was issued by the Defense Health Agency (DHA) to Nxstage Medical, Inc., a foreign-owned, for-profit medical device and supply manufacturer. The contract is a firm fixed-price purchase order for the supply of "CARTRIDGEPURIFICATI" equipment, with a completion date of December 4, 2020. Nxstage, which does business as Nxstage, specializes in producing advanced medical technologies for kidney failure treatment, including hemodialysis systems, water purification equipment, dialysate solutions, and related medical consumables. The company holds significant federal contract vehicles with the Department of Veterans Affairs, including a $3.125 million Federal Supply Schedule contract and a $50 million multiple-award indefinite delivery vehicle for the Veterans Health Administration Equipment Life Cycle Management Program. This contract award did not utilize any small business set-aside designations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Change Order | $1.4k | 11/28/20 | |
| Not listed | Not listed | $9.2k | 4/9/20 |